Dear Colleague,

Today, the U.S. Preventive Services Task Force (USPSTF or Task Force) posted a new discussion guide for clinicians and patients on preexposure prophylaxis (PrEP) for HIV prevention, entitled PrEP for HIV Prevention: Let’s Talk About It. 

The purpose of this guide is to facilitate meaningful discussions between clinicians and their patients who may be at higher risk for HIV to help determine which patients might be good candidates for PrEP. While the guide supports discussions around key questions related to HIV risk, it is not intended to be a risk assessment tool or decision aid. Written for a consumer audience, the guide also provides basic information about PrEP to help educate patients on this effective preventive medication.

This discussion guide supports the implementation of the USPSTF’s final recommendation on PrEP for Prevention of HIV Infection. The final recommendation can be found on the HIV PrEP topic page on the Task Force website and the guide is available under the “Related Resources & Tools” section. For your convenience, the guide is also attached to this email.    

If you have any questions, please let me know. Thank you for sharing this guide with your colleagues. 

Sincerely, 

Alex H. Krist, M.D., M.P.H. 

Chair, U.S. Preventive Services Task Force